Skip to main content
Contact us

Organic CDMO Companies
Organic Contract Manufacturing Services

Your Trusted Partners for Organic Contract Manufacturing and Development

Showing 44 facilities
CARBOGEN AMCIS | Aarau
Switzerland

CARBOGEN AMCIS | Aarau

CARBOGEN AMCIS

Desarrollo y fabricación cGMP a mediana escala, incluida la cromatografía

BATCH SIZE: Small, Medium

COMPLIANCE: PMDA/MHLW (Japan GMP), World Health Organization (GMP / HACCP), FDA (cGMP), ISO

CATEGORY / PRODUCT: SERVICES, OLIGONUCLEOTIDES, BIOLOGICS, CHEMICAL-SYNTHETIC

REGION: Europe

MARKETS: ANVISA (Brazil), PMDA (Japan), FDA (USA), CDSCO (India), EMA (EU), MFDS (South Korea), TGA (Australia), NMPA (China), Health Canada (Canada), MHRA (UK)

USE: Human, Veterinary

SERVICES: Analytical / QC services, Manufacturing services, Development services, Quality Assurance services

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 5,000 µg/day), 1 / low-hazard (PDE > 5,000 µg/day)

THERAPEUTIC AREAS OF EXPERTISE (ATC): (L) Antineoplastic and immunomodulating agents

CARBOGEN AMCIS | Bubendorf
Switzerland

CARBOGEN AMCIS | Bubendorf

CARBOGEN AMCIS

Desarrollo y fabricación cGMP de API de gran potencia, incluidos conjugados anticuerpo-fármaco (ADC)

MARKETS: DIGEMID (Peru), ANMAT (Argentina), Turkish Health Authorities, ANVISA (Brazil), ISP (Chile), PMDA (Japan), FDA (USA), MSPAS (Guatemala), CDSCO (India), EMA (EU), COFEPRIS (Mexico), MFDS (South Korea), TGA (Australia), NMPA (China), Health Canada (Canada), INVIMA (Colombia), MHRA (UK)

BATCH SIZE: Small, Medium

THERAPEUTIC AREAS OF EXPERTISE (ATC): (R) Respiratory system, (V09-10) Radiopharmaceuticals, (M) Musculoskeletal system, (L) Antineoplastic and immunomodulating agents, (C) Cardiovascular system, (A) Digestive tract and metabolism, (D) Dermatologicals, (N) Nervous system, (B) Blood and blood forming organs

COMPLIANCE: EMA (EU GMP), PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), World Health Organization (GMP / HACCP), FDA (cGMP), ISO

CATEGORY / PRODUCT: SERVICES, BIOLOGICS, CHEMICAL-SYNTHETIC

REGION: Europe

USE: Human, Veterinary

SERVICES: Analytical / QC services, Manufacturing services, Regulatory services, Development services, Quality Assurance services

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 5,000 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 1 / low-hazard (PDE > 5,000 µg/day), 3 (PDE = 100 - 1,000 µg/day)

CARBOGEN AMCIS | Vionnaz
Switzerland

CARBOGEN AMCIS | Vionnaz

CARBOGEN AMCIS

Desarrollo de principios activos muy potentes y producción a peque a escala según las normas cGMP, incluidas la cromatografía y la liofilización

BATCH SIZE: Small

COMPLIANCE: EMA (EU GMP), PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), World Health Organization (GMP / HACCP), FDA (cGMP), ISO

CATEGORY / PRODUCT: SERVICES, CHEMICAL-SYNTHETIC

REGION: Europe

MARKETS: ANVISA (Brazil), PMDA (Japan), FDA (USA), CDSCO (India), EMA (EU), MFDS (South Korea), TGA (Australia), NMPA (China), Health Canada (Canada), MHRA (UK)

USE: Human, Veterinary

SERVICES: Analytical / QC services, Manufacturing services, Development services, Quality Assurance services

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 5,000 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 1 / low-hazard (PDE > 5,000 µg/day), 3 (PDE = 100 - 1,000 µg/day)

Curapath
Spain

Curapath

Curapath

Soluciones para programas de administración no viral

MARKETS: DIGEMID (Peru), ANMAT (Argentina), Turkish Health Authorities, EDE (UAE), ANVISA (Brazil), ISP (Chile), PMDA (Japan), FDA (USA), MSPAS (Guatemala), CDSCO (India), Russian Health Authorities, EMA (EU), COFEPRIS (Mexico), MFDS (South Korea), SFDA (Saudi Arabia), TGA (Australia), NMPA (China), Health Canada (Canada), INVIMA (Colombia), MHRA (UK)

BATCH SIZE: Small, Medium

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS, SERVICES, PARTICLE ENGINEERING, CHEMICAL-SYNTHETIC

COMPLIANCE: EMA (EU GMP), World Health Organization (GMP / HACCP), FDA (cGMP), ISO

REGION: Europe

BSL (Biological Safety Level): 3, 1, 2

USE: Human, Veterinary

THERAPEUTIC AREAS OF EXPERTISE (ATC): (H) Systemic hormonal preparations excl. sex hormones and insulins, (G) Genito urinary system and sex hormones, (J) Antiinfectives for systemic use, (C) Cardiovascular system, (A) Digestive tract and metabolism, (D) Dermatologicals, (P) Antiparasitic products, insecticides and repellents

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 5,000 µg/day), 1 / low-hazard (PDE > 5,000 µg/day), 3 (PDE = 100 - 1,000 µg/day)

SERVICES: Manufacturing services, Regulatory services, Development services

CARBOGEN AMCIS | Shanghai, China
China

CARBOGEN AMCIS | Shanghai, China

CARBOGEN AMCIS

Fabricación a gran escala.

MARKETS: DIGEMID (Peru), ANMAT (Argentina), Turkish Health Authorities, EDE (UAE), ANVISA (Brazil), ISP (Chile), PMDA (Japan), FDA (USA), MSPAS (Guatemala), CDSCO (India), EMA (EU), COFEPRIS (Mexico), MFDS (South Korea), SFDA (Saudi Arabia), TGA (Australia), NMPA (China), Health Canada (Canada), INVIMA (Colombia), MHRA (UK)

BATCH SIZE: Small, Medium, Large

THERAPEUTIC AREAS OF EXPERTISE (ATC): (R) Respiratory system, (V01) Allergens, (M) Musculoskeletal system, (L) Antineoplastic and immunomodulating agents, (V04) Diagnostic agents, (S) Sensory organs, (J) Antiinfectives for systemic use, (C) Cardiovascular system, (A) Digestive tract and metabolism, (D) Dermatologicals, (N) Nervous system, (B) Blood and blood forming organs, (V06) Nutrients

CATEGORY / PRODUCT: SERVICES, OLIGONUCLEOTIDES, CHEMICAL-SYNTHETIC

USE: Human

COMPLIANCE: ANVISA (Brazil B-GMP), NMPA (China GMP)

SERVICES: Analytical / QC services, Logistics, Manufacturing services, Regulatory services, Development services, Packaging, Quality Assurance services

REGION: APAC

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 5,000 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 1 / low-hazard (PDE > 5,000 µg/day), 3 (PDE = 100 - 1,000 µg/day)

CARBOGEN AMCIS | Veenendaal
Netherlands

CARBOGEN AMCIS | Veenendaal

CARBOGEN AMCIS

Fabricación a gran escala de colesterol, vitamina D y análogos.

MARKETS: DIGEMID (Peru), ANMAT (Argentina), Turkish Health Authorities, EDE (UAE), ANVISA (Brazil), ISP (Chile), PMDA (Japan), FDA (USA), MSPAS (Guatemala), CDSCO (India), Russian Health Authorities, EMA (EU), COFEPRIS (Mexico), MFDS (South Korea), SFDA (Saudi Arabia), TGA (Australia), NMPA (China), Health Canada (Canada), INVIMA (Colombia), MHRA (UK)

BATCH SIZE: Small

THERAPEUTIC AREAS OF EXPERTISE (ATC): (R) Respiratory system, (V09-10) Radiopharmaceuticals, (H) Systemic hormonal preparations excl. sex hormones and insulins, (V01) Allergens, (M) Musculoskeletal system, (L) Antineoplastic and immunomodulating agents, (V04) Diagnostic agents, (S) Sensory organs, (G) Genito urinary system and sex hormones, (J) Antiinfectives for systemic use, (C) Cardiovascular system, (A) Digestive tract and metabolism, (D) Dermatologicals, (N) Nervous system, (P) Antiparasitic products, insecticides and repellents, (B) Blood and blood forming organs, (V06) Nutrients

COMPLIANCE: ISP (Chile BPM), Roszdravnadzor (Russia GMP), ANMAT (Argentina nueva GMP), EMA (EU GMP), PMDA/MHLW (Japan GMP), IFS, DIGEMID, UAE Ministry of Health & Prevention, ANVISA (Brazil B-GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP), French Service-Public (CIR), TGA (Australia GMP), FDA (cGMP), NSF, NMPA (China GMP), SFDA (Saudi Food & Drug Authority), BRCGS, ECOVADIS, ISO, Halal Research Council, INVIMA, Health Canada (Canada GMP), SQF (Safe Quality Food), TITCK (Turkish Health Authorities), MSPAS, MFDS/KFDA (Republic of Korea GMP), COFEPRIS

CATEGORY / PRODUCT: COSMETICS, SERVICES, CHEMICAL-SYNTHETIC

REGION: Europe

USE: Human, Veterinary

SERVICES: Analytical / QC services, Logistics, Manufacturing services, Regulatory services, Development services, Packaging, Quality Assurance services

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 5,000 µg/day), 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 1 / low-hazard (PDE > 5,000 µg/day), 3 (PDE = 100 - 1,000 µg/day)

BSL (Biological Safety Level): 1

CARBOGEN AMCIS | Manchester, UK
United Kingdom

CARBOGEN AMCIS | Manchester, UK

CARBOGEN AMCIS

Descubra nuestras capacidades de fabricación de ingredientes cosméticos, química fina y síntesis personalizada de productos farmacéuticos intermedios

BATCH SIZE: Small, Medium, Large

CATEGORY / PRODUCT: COSMETICS, SERVICES, OLIGONUCLEOTIDES, CHEMICAL-SYNTHETIC

REGION: Europe

USE: Human

SERVICES: Analytical / QC services, Logistics, Manufacturing services, Development services

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 5,000 µg/day), 1 / low-hazard (PDE > 5,000 µg/day)

COMPLIANCE: ECOVADIS, ISO, Halal Research Council

THERAPEUTIC AREAS OF EXPERTISE (ATC): (D) Dermatologicals

MARKETS: MHRA (UK)

CARBOGEN AMCIS | Neuland
Switzerland

CARBOGEN AMCIS | Neuland

CARBOGEN AMCIS

Desarrollo y fabricación a mediana escala

MARKETS: Turkish Health Authorities, ANVISA (Brazil), PMDA (Japan), FDA (USA), CDSCO (India), EMA (EU), MFDS (South Korea), TGA (Australia), NMPA (China), Health Canada (Canada), MHRA (UK)

BATCH SIZE: Small, Medium

COMPLIANCE: PMDA/MHLW (Japan GMP), World Health Organization (GMP / HACCP), FDA (cGMP)

CATEGORY / PRODUCT: SERVICES, CHEMICAL-SYNTHETIC

REGION: Europe

USE: Human, Veterinary

SERVICES: Analytical / QC services, Manufacturing services, Regulatory services, Development services, Quality Assurance services

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 5,000 µg/day), 1 / low-hazard (PDE > 5,000 µg/day), 3 (PDE = 100 - 1,000 µg/day)

Pharmaron API Commercial Synthesis Coventry (US)
United States

Pharmaron API Commercial Synthesis Coventry (US)

Pharmaron

Instalación comercial de moléculas peque as (RSM/API)

BATCH SIZE: Small, Medium, Large

THERAPEUTIC AREAS OF EXPERTISE (ATC): (R) Respiratory system, (H) Systemic hormonal preparations excl. sex hormones and insulins, (V01) Allergens, (M) Musculoskeletal system, (L) Antineoplastic and immunomodulating agents, (V04) Diagnostic agents, (S) Sensory organs, (G) Genito urinary system and sex hormones, (J) Antiinfectives for systemic use, (C) Cardiovascular system, (A) Digestive tract and metabolism, (D) Dermatologicals, (N) Nervous system, (P) Antiparasitic products, insecticides and repellents, (B) Blood and blood forming organs, (V06) Nutrients

CATEGORY / PRODUCT: SERVICES, CHEMICAL-SYNTHETIC

CONTROLLED SUBSTANCES: Lowest potential for abuse, High potential for abuse & no medical use, High potential for abuse & medical use, Lower potential for abuse, Low potential for abuse

USE: Human, Veterinary

MARKETS: PMDA (Japan), FDA (USA), EMA (EU), MFDS (South Korea), TGA (Australia), NMPA (China), Health Canada (Canada), MHRA (UK)

SERVICES: Logistics, Manufacturing services, Development services

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 5,000 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 1 / low-hazard (PDE > 5,000 µg/day), 3 (PDE = 100 - 1,000 µg/day)

REGION: North America

COMPLIANCE: FDA (cGMP), ECOVADIS, ISO

Viswa Laboratories Pvt Ltd
Spain

Viswa Laboratories Pvt Ltd

Viswa Laboratories Private Limited

CRAMS/CDMO, API, Productos intermedios y especialidades químicas

BATCH SIZE: Small, Medium, Large

THERAPEUTIC AREAS OF EXPERTISE (ATC): (R) Respiratory system, (M) Musculoskeletal system, (J) Antiinfectives for systemic use, (C) Cardiovascular system, (D) Dermatologicals

CATEGORY / PRODUCT: SERVICES, CHEMICAL-SYNTHETIC

REGION: Europe, APAC

MARKETS: ANVISA (Brazil), CDSCO (India), Russian Health Authorities, EMA (EU), NMPA (China)

USE: Human, Veterinary

COMPLIANCE: World Health Organization (GMP / HACCP)

SERVICES: Manufacturing services, Regulatory services, Development services

CONTROLLED SUBSTANCES: Lower potential for abuse

BSL (Biological Safety Level): 2

OEB (Occupational Exposure Banding): 3 (PDE = 100 - 1,000 µg/day)

Pharmaron API Commercial Synthesis Shaoxing (China)
China

Pharmaron API Commercial Synthesis Shaoxing (China)

Pharmaron

Instalación comercial de moléculas peque as (RSM/API) / péptidos

BATCH SIZE: Small, Medium, Large

THERAPEUTIC AREAS OF EXPERTISE (ATC): (R) Respiratory system, (V09-10) Radiopharmaceuticals, (H) Systemic hormonal preparations excl. sex hormones and insulins, (V01) Allergens, (M) Musculoskeletal system, (L) Antineoplastic and immunomodulating agents, (V04) Diagnostic agents, (S) Sensory organs, (G) Genito urinary system and sex hormones, (J) Antiinfectives for systemic use, (C) Cardiovascular system, (A) Digestive tract and metabolism, (D) Dermatologicals, (N) Nervous system, (P) Antiparasitic products, insecticides and repellents, (B) Blood and blood forming organs, (V06) Nutrients

USE: Human, Veterinary

SERVICES: Analytical / QC services, Manufacturing services, Regulatory services, Development services, Quality Assurance services

REGION: APAC

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 5,000 µg/day), 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 1 / low-hazard (PDE > 5,000 µg/day), 3 (PDE = 100 - 1,000 µg/day)

CATEGORY / PRODUCT: PARTICLE ENGINEERING, CHEMICAL-SYNTHETIC

MARKETS: FDA (USA), NMPA (China)

COMPLIANCE: FDA (cGMP), NMPA (China GMP), ISO

Apeloa Pharmaceutical Co., Ltd.
China

Apeloa Pharmaceutical Co., Ltd.

Apeloa Pharmaceutical Co., Ltd

Apeloa CDMO ofrece servicios de primer nivel en descubrimiento, desarrollo y fabricación de Ingredientes Farmacéuticos Activos (APIs), Intermedios y Materiales

MARKETS: DIGEMID (Peru), ANMAT (Argentina), Turkish Health Authorities, EDE (UAE), ANVISA (Brazil), ISP (Chile), PMDA (Japan), FDA (USA), MSPAS (Guatemala), CDSCO (India), Russian Health Authorities, EMA (EU), COFEPRIS (Mexico), MFDS (South Korea), SFDA (Saudi Arabia), TGA (Australia), NMPA (China), Health Canada (Canada), INVIMA (Colombia), MHRA (UK)

BATCH SIZE: Small, Medium, Large

COMPLIANCE: EMA (EU GMP), PMDA/MHLW (Japan GMP), World Health Organization (GMP / HACCP), FDA (cGMP), NMPA (China GMP), ECOVADIS, ISO

CATEGORY / PRODUCT: SERVICES, CHEMICAL-SYNTHETIC

USE: Human, Veterinary

SERVICES: Analytical / QC services, Manufacturing services, Regulatory services, Development services, Packaging

REGION: APAC

OEB (Occupational Exposure Banding): 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day)

More facilities on the network

Register to unlock the full catalog with contact details and locations.

+27 more facilities

Create free account

Organic synthesis is at the core of pharmaceutical innovation — enabling the creation of APIs, intermediates, and specialty compounds through precise, scalable chemistry. Whether you´re developing a novel therapeutic or manufacturing key starting materials, working with specialized organic CDMO companies ensures safety, quality, and efficiency throughout the process.

By outsourcing to experts in organic contract manufacturing, you gain access to advanced chemistry platforms, multi-step synthesis capabilities, and regulatory-ready infrastructure to accelerate your path from molecule to market.


How to Choose Organic CDMO Companies

When evaluating organic CDMO companies, important factors include:

  • Synthetic expertise: Heterocyclic chemistry, asymmetric synthesis, chiral resolution, complex multi-step routes

  • Development capabilities: Route scouting, process optimization, and impurity profiling

  • Scale flexibility: From lab to pilot to full commercial production

  • Reaction capabilities: Hydrogenation, halogenation, nitration, Grignard reactions, organometallic chemistry

  • Regulatory compliance: GMP, ISO, REACH, and inspection readiness (FDA, EMA, etc.)

  • Containment and safety systems for hazardous or sensitive reactions

The right CDMO combines chemistry know-how with operational control to deliver consistent results under tight timelines.


Key Services Offered by Organic Contract Manufacturers

Top-tier organic contract manufacturing providers typically offer:

  • Custom synthesis of APIs, intermediates, and reference standards

  • Route design and process development under GMP and non-GMP conditions

  • Hazardous and high-energy reaction handling with full safety systems

  • Pilot and commercial-scale production in multi-purpose reactors

  • Analytical method development and QC testing

  • Purification and crystallization for compound isolation and stability

  • Regulatory documentation and batch records for global submissions

  • Technology transfer and process validation

These services are ideal for pharma, biotech, agrochemical, and fine chemical applications.


Advantages of Partnering with Organic CDMO Companies

Collaborating with experienced organic CDMO companies provides clear benefits:

  • Accelerated development timelines with proven synthetic routes

  • Efficient scale-up from lab batches to metric ton production

  • High-purity output and impurity control for regulatory success

  • Cost-effective process optimization through route innovation

  • Compliance and documentation ready for audits and global filings

With the right CDMO, your molecule is developed, manufactured, and documented to meet both technical and market needs.


Organic CDMO Companies

Some of the most trusted organic CDMO companies include:

  • Cambrex: Chemical CMO specialized in the early development of small molecule pharmaceutical products, including organic contract manufacturing[See CDMO profile]

  • ChemCon: Based in Germany, ChemCon specializes in APIs and fine chemicals, offering expertise in transferring R&D projects into fully cGMP-compliant production processes. [See CDMO profile]

  • Pharmaron: Small molecule manufacturing facilities. [See CDMO profile]

  • Laboratori Alchemia: Custom synthesis of complex products or those which are even unknown in literature. [See CDMO profile]

  • Viswa Laboratories: CRAMS/CDMO, APIs, Intermediates and specialty chemicals. [See CDMO profile]

  • Actylis: Chemical Process Discovery, Development, cGMP, and Commercial Manufacturing Services. [See CDMO profile]

  • Seacross Pharma: With three facilities, Seacross Pharma provides a range of CMO/CDMO custom API services to global clients. [See CDMO profile]

  • CARBOGEN AMCIS: Development and cGMP manufacturing of Highly Potent APIs, including Antibody Drug Conjugates (ADCs). [See CDMO profile]

  • MENADIONA S.L: Contract development and manufacturing partner located in Spain for APIs, intermediates, and fine chemicals, specialized in transferring R&D projects into fully cGMP-compliant manufacturing processes. [See CDMO profile]

  • Apeloa Pharmaceutical Co: Provides world-class discovery, development, and manufacturing services for Active Pharmaceutical Ingredients (APIs), intermediates, and Registered Starting Materials (RSMs). [See CDMO profile]

  • SINOWAY INDUSTRIAL CO: One-stop CDMO solutions for APIs and key intermediates, supporting global clients from development to commercial scale. [See CDMO profile]

  • Synfine: Trusted manufacturer and exporter of a wide range of Active Pharmaceutical Ingredients (APIs) and intermediates, committed to quality and regulatory excellence. [See CDMO profile]

  • Demo facility: Tissue therapy, Cell therapy and GTMP (Gene Therapy). [See CDMO profile]

 


Related Information


Let MAI CDMO Help You Find the Right Organic CDMO Partner

At MAI CDMO, we connect pharma, biotech, and chemical companies with trusted organic CDMO companies offering top-tier organic contract manufacturing services. Whether you need route design, intermediate production, or full API synthesis, our network ensures you find the right partner for performance, compliance, and scalability.

 

Need a proven partner for complex organic synthesis? Contact us today and let’s get started.